Boiron SA is a leading pharmaceutical company specializing in the production and distribution of homeopathic medicines. Founded in 1932 by twin brothers Jean and Henri Boiron, pharmacists trained in s... Boiron SA is a leading pharmaceutical company specializing in the production and distribution of homeopathic medicines. Founded in 1932 by twin brothers Jean and Henri Boiron, pharmacists trained in science and microbiology, it originated as the Central Homeopathic Laboratory of France in Paris and formally incorporated as Laboratoires Boiron in 1967. Headquartered near Lyon in Ste. Foy-lès-Lyon, France, the company manufactures over 1,500 remedies, including mono-preparations, combination formulas, and popular over-the-counter products like Oscillococcinum for flu relief, Arnicare for pain, Stodal for coughs, and Arnigel. These are available in tablets, drops, syrups, ointments, and gels, emphasizing non-toxic therapeutic options. Boiron operates in more than 59 countries across Europe, North America, South America, Africa, the Middle East, Asia, and Australia, with subsidiaries and production facilities worldwide, maintaining compliance with stringent regulations like U.S. FDA standards and the Homeopathic Pharmacopoeia. As the world's largest homeopathic manufacturer, it supports scientific research, trains healthcare professionals, and holds a dominant position in the niche homeopathy market, which serves physicians and consumers seeking alternative remedies.
We have not yet reviewed Boiron's disclosures for Climate Targets data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.